Brown Advisory’s Sangamo Therapeutics SGMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-19,147
| Closed | -$33.7K | – | 1242 |
|
|
2023
Q1 | $33.7K | Buy |
19,147
+2,507
| +15% | +$4.41K | ﹤0.01% | 1194 |
|
|
2022
Q4 | $52.3K | Buy |
16,640
+3,500
| +27% | +$11K | ﹤0.01% | 1182 |
|
|
2022
Q3 | $64K | Sell |
13,140
-5,639
| -30% | -$27.5K | ﹤0.01% | 1109 |
|
|
2022
Q2 | $78K | Buy |
18,779
+6,176
| +49% | +$25.7K | ﹤0.01% | 1079 |
|
|
2022
Q1 | $73K | Buy |
12,603
+2,489
| +25% | +$14.4K | ﹤0.01% | 1092 |
|
|
2021
Q4 | $76K | Buy |
+10,114
| New | +$76K | ﹤0.01% | 1217 |
|